Save time and get answers to complex questions with AI chat
When will latisse patent expire?Atorvastatin side effects heart palpitations?Zemdri plazomicin nce gain exclusivity 2028 patent 2031?When is tenofovir alafenamide patent expiring?How to apply for vascepa's patient assistance?
See the DrugPatentWatch profile for Ramelteon
Ramelteon is a prescription sleep medicine classified as a melatonin receptor agonist, specifically a selective MT1/MT2 (melatonin) receptor agonist. It works by binding to melatonin receptors in the brain to help regulate sleep timing and promote sleep onset.
Because ramelteon targets melatonin receptors (MT1 and MT2), it’s not in the same drug classes as sedative-hypnotics like benzodiazepines (or “Z-drugs” such as zolpidem). Those drugs mainly act on GABA-A receptors to produce sedation. Melatonin-receptor–based therapies like ramelteon instead aim to shift or reinforce the body’s sleep-wake rhythm through melatonin pathways.
Ramelteon is used to treat insomnia, most often focusing on difficulty falling asleep.
It’s considered a hypnotic-type sleep medication, but its pharmacologic class is melatonin receptor agonist (not a sedative-hypnotic like benzodiazepines or GABA-A modulators, and not an antidepressant).
Other Questions About Ramelteon :